{"id":"W2913793077","doi":"10.1007/s11938-019-00222-9","title":"Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease","year":2019,"lang":"en","type":"review","venue":"Current Treatment Options in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Vedolizumab; Medicine; Therapeutic drug monitoring; Tofacitinib; Ustekinumab; Inflammatory bowel disease; Drug; Intensive care medicine; Infliximab; Pharmacology; Disease; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001365681,0.0009701822,0.002398548,0.001749339,0.0001987481,0.001418218,0.0009291659,0.001246048,0.003636434],"category_scores_gemma":[0.001839249,0.0002668572,0.0008771276,0.001666216,0.0005424065,0.001329062,0.00075033,0.002640088,0.001572379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000654015,"about_ca_system_score_gemma":0.00116061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007522918,"about_ca_topic_score_gemma":0.001357396,"domain_scores_codex":[0.9995394,0.0001115864,0.0000699395,0.00007478752,0.0001606409,0.00004373139],"domain_scores_gemma":[0.9988601,0.0007175575,0.0001466859,0.00002763215,0.0001951542,0.00005280727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001923283,0.00007211079,0.0002554999,0.008811929,0.0001080206,0.0001572277,0.00002194972,0.0004189477,0.00127385,0.002712434,0.01714261,0.9688331],"study_design_scores_gemma":[0.0001037077,0.0003237603,0.00146217,0.004978252,0.0004519597,0.001606639,0.00004976232,0.0005542445,0.001203208,0.004211354,0.9850085,0.00004643168],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009013443,0.9984941,0.0003086134,0.000337732,0.0001509214,0.000003812627,0.00002471146,0.00001215446,0.0005778735],"genre_scores_gemma":[0.001237293,0.9968516,0.0006334563,0.0004209801,0.0003514842,0.000008726237,0.00005017721,0.000003540325,0.0004428408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003636434,"threshold_uncertainty_score":0.01216501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04150820438250586,"score_gpt":0.3372733203136206,"score_spread":0.2957651159311147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}